Peripheral Electrical Stimulation for the Treatment of Overactive Bladder

Inclusion Criteria: * Males and Females, at least 18 years of age * Documented symptoms of idiopathic overactive bladder for at least 3 months * Failure on primary OAB treatment, such as behavior modification or fluid/diet management * Patients can remain on stable medication * Willing and capable of understanding and complying with all requirements of the protocol * Signed Informed Consent to participate in the study after full discussion of the research nature of the treatment and its risks and benefits Exclusion Criteria: * Urinary retention or post voiding residual greater than 100 ml * Clinically significant bladder outlet obstruction * Stress predominant mixed urinary incontinence * Neurological disease affecting urinary bladder function, including but not limited to Parkinson's disease, multiple sclerosis, stroke, spinal cord injury. * Pelvic surgery (such as sub-urethral sling, pelvic floor repair) within the past 6 months * Denovo OAB following pelvic surgery sub-urethral sling Intravesical or urethral sphincter Botulinum Toxin Type A injections within the past 6 months * Percutaneous Tibial Nerve Stimulation (PTNS) therapy for overactive bladder within the past 6 months * Any form of electric stimulation to the pelvis or lower limbs within 4 weeks * Vaginal prolapse greater than Stage II in the anterior compartment of the vagina using International Continence Society (ICS) Pelvic Organ ProlapseQuantification (POPQ) criteria. * Prior periurethral or transurethral bulking agent injections for bladder problems within the past 12 months. * History of pelvic radiation therapy * Any skin conditions affecting treatment sites * Lacking dexterity to properly utilize the components of the stimulator system. * Presence of an implanted electro-medical device (e.g. pacemaker, defibrillator, InterStim®, etc.), * Pregnant, nursing, suspected to be pregnant (by urine pregnancy method), or plans to become pregnant during the course of the study. * Recurrent Urinary Tract Infections UTI (\>3 UTI's in the past year) * History of, or current, lower tract genitourinary malignancies * Any clinically significant systemic disease or condition that in the opinion of the Investigator would make the patient unsuitable for the study * Any other clinical trial within 6 months